|
CSNK2A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.61278999999404E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.89660000000336E-05 |
| Normal-vs-Stage2 |
3.440100E-03 |
| Normal-vs-Stage3 |
1.6440199999912E-05 |
| Normal-vs-Stage4 |
1.200570E-04 |
| Stage1-vs-Stage2 |
8.601600E-01 |
| Stage1-vs-Stage3 |
2.823200E-01 |
| Stage1-vs-Stage4 |
4.680800E-01 |
| Stage2-vs-Stage3 |
3.682600E-01 |
| Stage2-vs-Stage4 |
4.637600E-01 |
| Stage3-vs-Stage4 |
9.298000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.75825999999546E-05 |
| Normal-vs-AfricanAmerican |
1.447370E-01 |
| Normal-vs-Asian |
4.172200E-04 |
| Caucasian-vs-AfricanAmerican |
1.444810E-01 |
| Caucasian-vs-Asian |
8.994000E-01 |
| AfricanAmerican-vs-Asian |
1.609360E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.27419999999645E-05 |
| Normal-vs-Female |
3.65780000000093E-05 |
| Male-vs-Female |
5.915000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.646200E-04 |
| Normal-vs-Age(41-60Yrs) |
2.01789999999535E-05 |
| Normal-vs-Age(61-80Yrs) |
1.379380E-04 |
| Normal-vs-Age(81-100Yrs) |
4.124200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.137800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.197800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.763600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.004800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.498400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.973200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.741600E-01 |
| Classical-VS-Follicular |
1.075570E-01 |
| Classical-VS-Other |
5.584400E-01 |
| Classical-VS-Normal |
2.192500E-04 |
| Tall-VS-Follicular |
9.031400E-01 |
| Tall-VS-Other |
9.767600E-01 |
| Tall-VS-Normal |
6.038700E-04 |
| Follicular-VS-Other |
9.771400E-01 |
| Follicular-VS-Normal |
1.178430E-04 |
| Other-VS-Normal |
5.905600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.32510000000019E-05 |
| Normal-vs-N1 |
1.78741999999898E-05 |
| N0-vs-N1 |
3.012800E-01 |
|
|
